FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Pain

  • Home
  •  | 
  • Tag Archives: "Pain"

Aleafia Health to Accelerate Research Division with Appointment of Product Data Science Fellow

Aleafia Health to Accelerate Research Division with Appointment of Product Data Science Fellow
Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”), has appointed Dr. Graham Merry, as the Company’s first Product Data Science Fellow. Leveraging the Company’s proprietary 10 million point medical cannabis patient dataset, Dr. Merry will lead Aleafia Health’s ongoing medical cannabis research. These efforts will be aimed at developing evidence-based, proprietary treatment methods and products for chronic illnesses including pain, insomnia, anxiety and eating disorders.
Read more

Veritas Signs MOU with Israeli Cannabis Industry Leader IsCann Group Limited

Veritas Signs MOU with Israeli Cannabis Industry Leader IsCann Group Limited
Veritas Signs MOU with Israeli Cannabis Industry Leader IsCann Group Limited VANCOUVER, British Columbia, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has signed a Memorandum of Understanding (“MOU”) with IsCann Group Limited (“IsCann”) located in Be'er Tuvya, Israel…
Read more

Tetra Bio-Pharma Takes on Fentanyl in Head to Head Trial for the Treatment of Breakthrough Pain

Tetra Bio-Pharma Takes on Fentanyl in Head to Head Trial for the Treatment of Breakthrough Pain
Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development (TSX VENTURE:TBP) (OTCQB:TBPMF), is pleased to announce that Santé Cannabis, the independently credentialed research organization they work with has finalized the clinical study protocol evaluation of PPP001, which will be the first time that cannabis is being compared to fentanyl in a clinical trial. The study protocol has received approval from the Independent Ethics Board (IRB Services) and was recently submitted for review to Health Canada. PPP001 will investigate cannabis as an alternative to fentanyl in the management of breakthrough pain.  Santé Cannabis is a Quebec-based medical clinic specialized in clinical research and cannabis - based therapies.
Read more